Koncen Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 405

Employees

  • Latest Deal Type
  • IPO
  • (Cancelled)

  • Investors
  • 4

Koncen General Information

Description

Developer of medical technology intended to offer blood-purification. The company's technology helps to accelerate blood dialysis and blood purification adsorption, enabling healthcare providers to save the lives of the patients.

Contact Information

Website
www.koncen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • No. 8 Shenzhou Street, Science City
  • High-tech Industrial Development Zone
  • Guangzhou, Guangdong 510660
  • China
+86 020
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • No. 8 Shenzhou Street, Science City
  • High-tech Industrial Development Zone
  • Guangzhou, Guangdong 510660
  • China
+86 020

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Koncen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. IPO 11-Jul-2024 Cancelled Generating Revenue
4. Secondary Transaction - Private 28-May-2019 Completed Generating Revenue
3. Later Stage VC 29-Mar-2018 Completed Generating Revenue
2. Later Stage VC 01-Jan-2013 $66.5K Completed Generating Revenue
1. Seed Round 18-Jul-2001 $66.5K $66.5K Completed Startup
To view Koncen’s complete valuation and funding history, request access »

Koncen Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Koncen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4331701-A1 Modified macroporous adsorption resin, preparation method therefor and use thereof Pending 28-May-2021
EP-4331701-A4 Modified macroporous adsorption resin, preparation method therefor and use thereof Pending 28-May-2021
EP-4074733-A1 Immunoglobulin binding protein, preparation method and application thereof Pending 06-Dec-2019
EP-4074733-A4 Immunoglobulin binding protein, preparation method and application thereof Pending 06-Dec-2019
EP-3919097-A1 Encapsulation structure of blood plasma adsorber and adsorbent thereof Active 29-Jan-2019 A61M1/38
To view Koncen’s complete patent history, request access »

Koncen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Koncen Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hongshan Capital Group Venture Capital Minority
Hyfinity Investments Venture Capital Minority
Wens Investment (Guangdong) Corporate Venture Capital Minority
Guangzhou Financial Innovation Investment Venture Capital Minority
To view Koncen’s complete investors history, request access »

Ready to get started?

Request a free trial

Koncen FAQs

  • When was Koncen founded?

    Koncen was founded in 2001.

  • Where is Koncen headquartered?

    Koncen is headquartered in Guangzhou, China.

  • What is the size of Koncen?

    Koncen has 405 total employees.

  • What industry is Koncen in?

    Koncen’s primary industry is Biotechnology.

  • Is Koncen a private or public company?

    Koncen is a Private company.

  • What is Koncen’s current revenue?

    The current revenue for Koncen is .

  • How much funding has Koncen raised over time?

    Koncen has raised $66.5K.

  • Who are Koncen’s investors?

    Hongshan Capital Group, Hyfinity Investments, Wens Investment (Guangdong), and Guangzhou Financial Innovation Investment have invested in Koncen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »